284 related articles for article (PubMed ID: 24279335)
21. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
22. The rho guanosine 5'-triphosphatase, cell division cycle 42, is required for insulin-induced actin remodeling and glucagon-like peptide-1 secretion in the intestinal endocrine L cell.
Lim GE; Xu M; Sun J; Jin T; Brubaker PL
Endocrinology; 2009 Dec; 150(12):5249-61. PubMed ID: 19819966
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.
Humphries-Bickley T; Castillo-Pichardo L; Hernandez-O'Farrill E; Borrero-Garcia LD; Forestier-Roman I; Gerena Y; Blanco M; Rivera-Robles MJ; Rodriguez-Medina JR; Cubano LA; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422
[TBL] [Abstract][Full Text] [Related]
24. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1-Related Signaling Pathways.
Zhou Y; Zhang J; Wang J; Cheng MS; Zhao DM; Li F
Anat Rec (Hoboken); 2019 Sep; 302(9):1571-1579. PubMed ID: 30773850
[TBL] [Abstract][Full Text] [Related]
25. A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis.
Wang D; Paria BC; Zhang Q; Karpurapu M; Li Q; Gerthoffer WT; Nakaoka Y; Rao GN
Circ Res; 2009 May; 104(9):1066-75. PubMed ID: 19359598
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth.
Aguilar BJ; Zhao Y; Zhou H; Huo S; Chen YH; Lu Q
Cancer Biol Ther; 2019; 20(6):740-749. PubMed ID: 30849276
[TBL] [Abstract][Full Text] [Related]
27. Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway.
Liu C; Zhang L; Cui W; Du J; Li Z; Pang Y; Liu Q; Shang H; Meng L; Li W; Song L; Wang P; Xie Y; Wang Y; Liu Y; Hu J; Zhang W; Li F
EBioMedicine; 2019 Dec; 50():122-134. PubMed ID: 31761617
[TBL] [Abstract][Full Text] [Related]
28. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.
Kumar A; Al-Sammarraie N; DiPette DJ; Singh US
Oncotarget; 2014 Nov; 5(22):11709-22. PubMed ID: 25365944
[TBL] [Abstract][Full Text] [Related]
29. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.
Huynh N; Liu KH; Baldwin GS; He H
Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063
[TBL] [Abstract][Full Text] [Related]
30. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
Ip CK; Cheung AN; Ngan HY; Wong AS
Oncogene; 2011 May; 30(21):2420-32. PubMed ID: 21258406
[TBL] [Abstract][Full Text] [Related]
31. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
33. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT
Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534
[TBL] [Abstract][Full Text] [Related]
34. Progress in the therapeutic inhibition of Cdc42 signalling.
Murphy NP; Mott HR; Owen D
Biochem Soc Trans; 2021 Jun; 49(3):1443-1456. PubMed ID: 34100887
[TBL] [Abstract][Full Text] [Related]
35. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
36. Activation of Dbl restores migration in polyamine-depleted intestinal epithelial cells via Rho-GTPases.
Ray RM; Bavaria MN; Bhattacharya S; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G988-97. PubMed ID: 21372162
[TBL] [Abstract][Full Text] [Related]
37. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.
Licciulli S; Maksimoska J; Zhou C; Troutman S; Kota S; Liu Q; Duron S; Campbell D; Chernoff J; Field J; Marmorstein R; Kissil JL
J Biol Chem; 2013 Oct; 288(40):29105-14. PubMed ID: 23960073
[TBL] [Abstract][Full Text] [Related]
38. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells.
Sells MA; Knaus UG; Bagrodia S; Ambrose DM; Bokoch GM; Chernoff J
Curr Biol; 1997 Mar; 7(3):202-10. PubMed ID: 9395435
[TBL] [Abstract][Full Text] [Related]
39. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.
Geng A; Luo L; Ren F; Zhang L; Zhou H; Gao X
BMC Cancer; 2021 Jul; 21(1):843. PubMed ID: 34289832
[TBL] [Abstract][Full Text] [Related]
40. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.
Fortin SP; Ennis MJ; Schumacher CA; Zylstra-Diegel CR; Williams BO; Ross JT; Winkles JA; Loftus JC; Symons MH; Tran NL
Mol Cancer Res; 2012 Jul; 10(7):958-68. PubMed ID: 22571869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]